For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

We use cookies to make our site as useful as possible.

Our Cookie Policy explains how you can opt-out of the cookies we use.

If you continue without changing your cookie settings, we'll assume you’re happy with this.

Continue Continue

United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Diagnostic & Therapeutic Solutions
    Custom solutions & partnerships

    Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.

    Create custom solutions with us

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Supporting our customers and employees during the COVID-19 pandemic. Read more

Custom antibody development FAQs

Related

  • Commercial partnerships
    • Custom antibody development and production
      • RabMAb monoclonal antibodies

        Answers to some of the most common questions about our custom antibody generation services.

        Overview

        • What services do you provide?
        • What platforms do you use for custom antibody discovery?
        • Why rabbit?
        • Can you give more information on your different platforms?
        • How do you select antibodies that meet my specific requirements?
        • Can you give examples of the types of assays/testing that can be performed during a custom project?
        • How are your antibodies produced?
        • What can your antibodies be used for?
        • What quality systems do you have in place?
        • What is the timeframe for developing a custom antibody?
        • What kinds of antigens/immunogens can you use?
        • How much does it cost to develop a custom antibody?
        • Will the antibody be sold on Abcam’s catalog?
        • Do you support GMP production?
        • Can you support the engineering of the antibody?
        • Can antibodies be humanized for therapeutic purposes?


        What services do you provide?

        We provide comprehensive solutions for custom antibody development, with the ability to go from initial target evaluation through to delivery of purified fit-for-purpose antibody for research, diagnostic or therapeutic application.

        We have highly experienced teams dedicated to antibody discovery for custom projects. We design and execute tailor-made discovery and selection strategies to generate and select binders that meet your desired antibody specifications.

        What platforms do you use for custom antibody discovery?

        We will utilize the most appropriate technology dependent upon the target of interest, antibody requirements, and customer timelines.

        We have comprehensive antibody discovery platforms that we deploy as required to achieve the goal of each custom antibody discovery program.

        Why rabbit?

        The unique features of the rabbit immune system make it ideal for antibody generation, particularly to challenging targets.  Rabbits generate an expansive B-cell repertoire due to reliance on a gene-conversion mechanism in concert with somatic hypermutation during B-cell development. 

        The rabbit’s immune system supports the generation of a diverse selection of antibodies that can differentiate between even the most subtle structural variants, such as post-translational modifications, point mutations, and epigenetic targets. The diverse epitope recognition found in the rabbit also helps in identifying high-sensitivity antibody pairs. Additionally, rabbits possess a single subclass of IgG, removing the need for isotyping and allowing direct comparison of candidates at an early stage in screening cascades.

        Can you give more information on your different platforms?

        RabMAb antibody discovery

        Hybridoma-based

        • Our RabMAb antibody discovery platform is built on rabbit hybridoma technology to generate highly specific, recombinant antibodies.
        • Use of our proprietary rabbit fusion cell line increases the stability of the resulting hybridoma lines compared to standard heterogenous myeloma production.
        • The number of target-specific clones that meet challenging selection criteria is maximized in our selection process, via both B-cell enrichment and the broad epitope diversity delivered by the rabbit immune response.
        • Sequencing positive hybridoma clones at an early stage in the selection process allows us to accelerate the selection process and allows you to test a range of sequence-unique clones to generate a final fit-for-purpose recombinant antibody.


        B-cell cloning

        • The second arm of our RabMAb discovery platform interrogates circulating or splenic, high-secreting B cells, likely plasma cells to identify high affinity antibodies, faster. 
        • Peripheral blood cells (or lymphoid residing cells) are isolated and the recombinant antibody product is selected from antigen-binding candidates.
        • Initially, oligoclonal recombinant Ab pools are screened, followed by molecular subcloning to ensure monoclonality of the final recombinant antibody.


        Next-Generation Sequencing

        • Our proprietary NGS platform, with full bioinformatic analytic support, builds upon the diversity of the rabbit immune system, enabling mining of the breadth and depth of the immune response, to give a bioinformatic blueprint of target-reactive recombinant antibodies.
        • Maximum antibody diversity and rare antibody clones with specific binding characteristics can be identified through analysis of the full immune repertoire.
        • Optimal antibody selection can be performed, with native light and heavy chain pairing, using our single-cell sequencing and proprietary bioinformatic platform.
        • NGS is well-suited for combination with recombinant RabMAb approaches to allow lineage mining for discovery and optimization on especially challenging targets or needs.


        Phage display

        If an in vivo approach to antibody generation can’t be used, e.g., the target is toxic or non-immunogenic, we can combine our phage display technology with our other antibody discovery platforms to generate highly sensitive and specific antibodies for your needs.

        • Phage display utilizes high-diversity libraries based on human-derived sequences in a single-chain variable fragment (scFvs) format.
        • Diversity and target specificity of the selected clone can be maximized using our proprietary affinity maturation technology.
        • Pre-existing Ab can also be engineered using this technology to give enhanced performance.
        • The scFv are converted to IgG for provision.

        How do you select antibodies that meet my specific requirements?

        In addition to selecting the optimum antibody discovery platform (or combination of platforms), tailor-made assay cascades are designed for each custom antibody discovery project.

        Our assay cascades detail the screens and any application-specific tests that will be executed to ensure identification of the best antibody for your specific requirements in terms of selectivity, sensitivity and application performance.

        Can you give examples of the types of assays/ testing that can be performed during a custom project?

        Assay capabilities

        (including but not limited to)

        • Homogeneous high throughput biochemical binding assays (TR-FRET)
        • High throughput pair finding
        • LOQ/LOD determination
        • Matrix Tolerance Assay
        • Ligand/receptor neutralization
        • Functional assays
        • Cell-based binding assays
        • Reporter assays and competition assays
        • Internalization assays
        • ADCC reporter assay


        Application-specific screening

        • ELISA
        • Western Blot
        • IHC
        • ICC
        • Flow cytometry

        How are your antibodies produced?

        All our custom antibodies are sequenced, cloned, and produced in a recombinant system. This ensures high antibody yields, batch-to-batch consistency, and sustainable long-term supply.

        What can your antibodies be used for?

        We can produce antibodies for use in research, diagnostics* and as therapeutics*.

        In the IVD space, we have agreements in place with several leading IVD manufacturers, that enable us to act as a single point of contact to transition reagents from research onto multiple IVD platforms.

        More details on our partnership strategy can be found here.


        What quality systems do you have in place?

        Our RabMAb antibody manufacturing site is ISO 9001:2015 certified and all other sites work to these standards.

        Our In Vitro Diagnostics (IVD) group is registered with the USFDA and operates under USFDA Quality System Regulation (21 CFR Part 820) and in compliance with ISO 13485:2016. This facility and its quality system have a Medical Device Manufacturing License granted by the California Department of Public Health (CDPH).

        What is the timeframe for developing a custom antibody?

        The timelines for custom antibody development are dependent upon the complexity of each project and the technological and engineering requirements needed to identify an antibody that meets the specific end-user needs.

        The approximate timeframes for antibody development and delivery of a purified antibody are in the range of 5-9 months, including NGS services, with indications of success from as early as 2 months.

        What kinds of antigens/immunogens can you use?

        We routinely work with a wide variety of immunogens including

        • Recombinant protein
        • Peptide (+/- post-translational modification)
        • Over-expressing cell lines
        • Small molecules (such as nucleotides, organic chemicals, eg PEG)
        • Toxins
        • Polysaccharides

        How much does it cost to develop a custom antibody?

        The costs for custom-antibody generation are dependent upon project requirements. 

        A costed proposal is developed on a case-by-case basis and will be discussed with you before the project starts.

        Will the antibody be sold on Abcam’s catalog?

        For some customers, it can be beneficial to have their specific reagent validated by our global customer base and it is possible to agree commercial terms that will allow the reagent to be included in our portfolio for Research Use Only.

        Do you support GMP production?

        We can support antibody and assay development to a GMP-ready position and then work with you to transfer your antibody to a partner for GMP manufacture.  We can also support GMP manufacture for use in immunohistochemistry.

        Can you support the engineering of the antibody?

        Following discovery, if appropriate, we can support a variety of antibody engineering options, including:

        • Fc switches
        • Removal of manufacturing sequence liabilities
        • Enhancements to Tm
        • Full engineering of properties via generation of phage display variant libraries, with tailor-made selection and assays to select for required improvements.


        Can antibodies be humanized for therapeutic purposes?

        Several RabMAb antibodies have been successfully humanized for therapeutic use. We work with a partner organization to carry out humanization on a case by case basis. 

        We also support CDR grafting to selected frameworks, using phage display as an intermediate to confirm engineered Ab performance.


        *Subject to commercial terms and conditions. Please contact partnerships@abcam.com for more information.




        Get in touch with us


        Get resources and offers direct to your inbox Sign up
        A-Z by research area
        • Cancer
        • Cardiovascular
        • Cell biology
        • Developmental biology
        • Epigenetics & Nuclear signaling
        • Immunology
        • Metabolism
        • Microbiology
        • Neuroscience
        • Signal transduction
        • Stem cells
        A-Z by product type
        • Primary antibodies
        • Secondary antibodies
        • Biochemicals
        • Isotype controls
        • Flow cytometry multi-color selector
        • Kits
        • Loading controls
        • Lysates
        • Peptides
        • Proteins
        • Slides
        • Tags and cell markers
        • Tools & Reagents
        Help & support
        • Support
        • Make an Inquiry
        • Protocols & troubleshooting
        • Placing an order
        • RabMAb products
        • Biochemical product FAQs
        • Training
        • Browse by Target
        Company
        • Corporate site
        • Investor relations
        • Company news
        • Careers
        • About us
        • Blog
        Events
        • Tradeshows
        • Conferences
        International websites
        • abcam.cn
        • abcam.co.jp

        Join with us

        • LinkedIn
        • facebook
        • Twitter
        • YouTube
        • Terms of sale
        • Website terms of use
        • Cookie policy
        • Privacy policy
        • Legal
        • Modern slavery statement
        © 1998-2021 Abcam plc. All rights reserved.